Kobayashi Takashi

Research field (1)： Urology

Research theme for competitive and other funds (11)：

2022 - 2025 患者由来ゼノグラフトを用いたCDK12変異前立腺癌のPARP阻害薬不応性の克服
2022 - 2025 遺伝子改変尿路上皮オルガノイドによる膀胱発癌メカニズムの解明と免疫治療のモデル化
2021 - 2024 前立腺導管癌の分子生物学的特徴及び治療予測への人工知能の応用
2021 - 2024 Development of novel biomarkers based on HLA epitopes for organ transplantation and hematopoietic stem cell transplantation
2019 - 2022 Establishment of a novel mouse model that recapitulates human muscle invasive bladder cancer

Show all

Papers (287)：

Fumihiko Urabe, Takayuki Sumiyoshi, Kojiro Tashiro, Takayuki Goto, Takahiro Kimura, Takashi Kobayashi. Prostate cancer and liquid biopsies: Clinical applications and challenges. International Journal of Urology. 2024
Makito Miyake, Hiroshi Kitamura, Nobutaka Nishimura, Tatsuki Miyamoto, Tomonori Nakahama, Tomomi Fujii, Hiroaki Matsumoto, Hideyasu Matsuyama, Masaya Yonemori, Hideki Enokida, et al. Validation of non-muscle-invasive bladder cancer risk stratification updated in the 2021 European Association of Urology guidelines. BJUI compass. 2024. 5. 2. 269-280
Atsuro Sawada, Masashi Takeda, Takayuki Goto, Shusuke Akamatsu, Takashi Kobayashi. Renal cell carcinoma with multiple bone metastases effectively treated by a combination of tyrosine kinase inhibitor, robot-assisted partial nephrectomy, and metastasectomy. Clinical Case Reports. 2024
Hiroshi Kikuchi, Takashige Abe, Makito Miyake, Haruka Miyata, Ryuji Matsumoto, Takahiro Osawa, Nobutaka Nishimura, Kiyohide Fujimoto, Junichi Inokuchi, Takahiro Yoneyama, et al. The impact of second transurethral resection on survival outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin therapy. Japanese Journal of Clinical Oncology. 2024. 54. 2. 192-200
Takashi Matsuoka, Aiko Sugiyama, Yoshifumi Miyawaki, Yusuke Hidaka, Yukiko Okuno, Hiroaki Sakai, Hiroki Tanaka, Kiyotsugu Yoshikawa, Tomohiro Fukui, Kei Mizuno, et al. Newly developed preclinical models reveal broad-spectrum CDK inhibitors as potent drugs for CRPC exhibiting primary resistance to enzalutamide. Cancer science. 2024. 115. 1. 283-297

ｍore...

MISC (97)：

菊池茜恵, 沼倉一幸, 三宅牧人, 小林瑞貴, 武藤弓奈, 関根悠哉, 田岡利宜也, 小林恭, 小島崇宏, 北村寛, et al. 筋層非浸潤性膀胱癌に対するBCG膀胱内注入療法後の上部尿路腫瘍の検討. 泌尿器外科. 2023. 36. 6. 552-554
澤田篤郎, 曲渕敏博, 浜田彬弘, 増井仁彦, 小枝正直, 小林恭. Development of a surgical support system for robot-assisted partial nephrectomy using highly versatile augmented reality and challenging problems. 日本泌尿器科学会総会(Web). 2023. 110th
清水浩介, 佐野剛視, 畑野翔太郎, 服部悠斗, 羽間悠祐, 藤原裕士, 河野仁, 増井仁彦, 佐藤琢磨, 後藤祟之, et al. ペンブロリズマブが著効したMSI-highの去勢抵抗性前立腺癌の1例. 泌尿器科紀要. 2022. 68. 12
高森一, 井上貴博, 萩本裕樹, 杉山恭平, 宗宮伸弥, 住吉崇幸, 嘉島相輝, 吉野喬之, 後藤崇之, 澤田篤郎, et al. 再発巣摘除で治癒しえた前立腺癌放射線治療後の異所性精嚢転移の1例. 泌尿器科紀要. 2022. 68. 1
沼倉一幸, 三宅牧人, 小林瑞貴, 武藤弓奈, 田岡利宜也, 小林恭, 小島崇宏, 北村寛, 西山博之, 藤本清秀, et al. 筋層非浸潤性膀胱癌に対するBCG膀胱内注入療法施行後の上部尿路癌のリスク因子(Risk factors of subsequent upper urinary tract carcinoma treated with intravesical bacillus Calmette-Guerin therapy for non-muscle-invasive bladder cancer). 日本泌尿器科学会総会. 2021. 109回. ISA03-06

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page